-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Akebia Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2017 to Q3 2024.
- Akebia Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 210M shares, a 11.7% increase year-over-year.
- Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 187M shares, a 2.56% increase from 2022.
- Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 183M shares, a 10.1% increase from 2021.
- Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 166M shares, a 19.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)